Eli Lilly & Co.
(NYSE : LLY)

( )
LLY PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -0.38%159.500.7%$1204.05m
PFEPfizer Inc. 0.38%37.330.9%$1008.82m
MRKMerck & Co., Inc. 0.29%76.650.7%$969.50m
ABBVAbbVie, Inc. 0.28%106.301.9%$822.66m
BMYBristol-Myers Squibb Co. -0.06%63.801.0%$725.39m
LLYEli Lilly & Co. 0.07%183.131.1%$599.57m
AZNAstraZeneca Plc 0.92%50.301.2%$444.76m
GSKGlaxoSmithKline Plc -1.54%35.570.2%$176.30m
RPRXRoyalty Pharma Plc 0.00%42.120.2%$163.20m
NVSNovartis AG 0.04%86.780.2%$149.12m
VTRSViatris, Inc. 0.00%13.210.0%$129.35m
CVACCureVac NV 6.76%109.550.0%$88.64m
RGENRepligen Corp. 0.00%205.296.8%$87.69m
ATNF180 Life Sciences Corp. 1.34%10.600.0%$63.51m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 0.16%74.920.0%$61.28m

Company Profile

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The firm's products consist of Diabetes, Oncology, Immunology, Neuroscience, and Other therapies. The Diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta, and Trulicity. The Oncology products consist of Alimta, Cyramza, Erbitux, Retevmo, Tyvyt, and Verzenio. The Immunology products include Olumiant and Taltz. The Neuroscience products consist of Cymbalta, Emgality, Reyvow, and Zyprexa. The Other therapies include Bamlanivimab, Cialis, and Forteo.The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.